<![CDATA[FSGS in focus: Interpreting DUPLEX trial data for clinical practice and payer policy: Written recap]]>

Дата публикации: 13-10-2026 13:59:33

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Capricor’s data clash and a fugitive in the C-suite	0	12.07	30-07-2026
2	STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more	0	10.35	28-07-2026
3	STAT+: Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more	0	7.23	30-07-2026
4	<![CDATA[Why biosimilars keep losing ground to brand-name rivals: A Q&A with Christine Johnston, MBA]]>	0	12.66	14-10-2026
5	STAT+: Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and more	0	5	09-07-2026
6	Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer	0	11.1	13-07-2026
7	Senators question whether military pharmacy program is the best deal for beneficiaries	0	9.7	16-07-2026
8	Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days	0	5	31-07-2025
9	STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more	0	5.8	14-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 6.69. Источник: www.managedhealthcareexecutive.com.